SOMERSET, N.J., Aug. 4, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV) (“inVentiv”), a leading provider of end-to-end clinical development, launch and commercialization services to the global pharmaceutical and healthcare industries, today announced the completion of the transaction providing for the acquisition of inVentiv Health, Inc. by inVentiv Group Holdings, Inc. (formerly Papillon Holdings, Inc.), an entity created and funded by certain affiliates of Thomas H. Lee Partners, L.P. (“THL”), Liberty Lane Partners, LLP (“Liberty Lane”), certain co-investors and members of the inVentiv management team.
